The weekly litigation news digest is live. Subscribe now

Medivation Prostate Therapeutics competitive analysis

Loading summary...

Explore Medivation Prostate Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
Aug 18, 2021Formulations Of Enzalutamide12
Aug 22, 2018Treatment Of Breast Cancer1

Latest PTAB cases involving Medivation Prostate Therapeutics

Discover the latest PTAB cases involving Medivation Prostate Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Medivation Prostate Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDIVATION PROSTATE THERAPEUTICS - 13 - -
ALFRED E TIEFENBACHER443 - -
BULLE DR19 - - -
HAMM & WITTKOPP113 - - -